Walleye Trading
ESPR

Walleye Trading’s Esperion Therapeutics ESPR Stock Holding History

Walleye Trading’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5K Buy
12,593
+8,730
+226% +$27.6K ﹤0.01% 3769
2025
Q4 		$14.3K Buy
+3,863
New +$12.5K ﹤0.01% 4135
2022
Q4 		– Sell
-14,170
Closed -$101K – 5070
2022
Q3 		$95K Buy
+14,170
New +$97.3K ﹤0.01% 4068
2022
Q1 		– Sell
-166,549
Closed -$714K – 5465
2021
Q4 		$833K Buy
166,549
+96,225
+137% +$770K ﹤0.01% 2413
2021
Q3 		$847K Buy
+70,324
New +$1.02M ﹤0.01% 2392
2019
Q3 		– Sell
-2,886
Closed -$114K – 4126
2019
Q2 		$134K Buy
2,886
+1,789
+163% +$84K ﹤0.01% 3176
2019
Q1 		$44K Sell
1,097
-905
-45% -$40.6K ﹤0.01% 3762
2018
Q4 		$92K Buy
+2,002
New +$96.5K ﹤0.01% 3924

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return